This training will review the new diagnostic criteria in the DSM-V related to the substance use disorders as well as each of the major categories of the substances of abuse. The substances reviewed will include the narcotics, the stimulants, the sedative-hypnotics including alcohol, the hallucinogens, as well the latest designer drugs. In addition, the current issues related to vaping and commonly misused medication will be reviewed. Participants will also review current medication assisted treatments used to assist clients in stabilization and recovery from the substance use disorders.
Opioids
The words we choose have an impact. How we talk about drug use and people who use drugs is informed by our preconceived notions and internalized biases. When we use words like “clean,” we necessarily imply that the opposite is “dirty.” Opioid Use Disorder continues to be a highly stigmatized medical condition, despite many advancements in our understanding of the neurobiological, social, and environmental determinants that impact individual health. People with an Opioid Use Disorder continue to report high rates of discrimination from medical providers, service denials from government entities, and continued unfair targeting by law enforcement. The ramifications of stigma in care environments are far reaching and further compound the opioid crisis. During this workshop, participants will explore personal biases related to opioid use and examine the way that these biases present in language. We will consider the effects that stigmatizing speech and actions have on people who use drugs, and we will discuss how to create an affirming environment that will enhance care for people who use drugs. Registration fee includes a continental breakfast and lunch.
2019 Clinical Opioid Update: Learning Objectives:
- Review latest research relating to opioid + pain prescribing practices
- Constantly consider harm reduction
- Discuss opioid use disorder and treatments
2019 Legal Opioid Update: Learning Objectives:
- Review impact of Chapter 488 in Maine
- Discuss opioid laws, rules and initiatives of the new administration
- Study Chapter 21 requirements & logical implementation
- Investigate methods to further transform local and regional prescribing
Co-Prescribing Benzodiazepines and Opioids: The Black Box of Increased Overdose Risk: Learning Objectives:
- Review the trends in benzodiazepine prescribing
- Evaluate risks of co-prescribing benzodiazepines and opioids
- Consider taper plans
- Recall importance of risk reduction
Registration is Free – Advanced Registration is required. Light snacks will be provided.
2019 Clinical Opioid Update: Learning Objectives:
- Review latest research relating to opioid + pain prescribing practices
- Constantly consider harm reduction
- Discuss opioid use disorder and treatments
2019 Legal Opioid Update: Learning Objectives:
- Review impact of Chapter 488 in Maine
- Discuss opioid laws, rules and initiatives of the new administration
- Study Chapter 21 requirements & logical implementation
- Investigate methods to further transform local and regional prescribing
Co-Prescribing Benzodiazepines and Opioids: The Black Box of Increased Overdose Risk: Learning Objectives:
- Review the trends in benzodiazepine prescribing
- Evaluate risks of co-prescribing benzodiazepines and opioids
- Consider taper plans
- Recall importance of risk reduction
Registration is Free – Advanced Registration is required. Light snacks will be provided.
2019 Clinical Opioid Update: Learning Objectives:
- Review latest research relating to opioid + pain prescribing practices
- Constantly consider harm reduction
- Discuss opioid use disorder and treatments
2019 Legal Opioid Update: Learning Objectives:
- Review impact of Chapter 488 in Maine
- Discuss opioid laws, rules and initiatives of the new administration
- Study Chapter 21 requirements & logical implementation
- Investigate methods to further transform local and regional prescribing
Co-Prescribing Benzodiazepines and Opioids: The Black Box of Increased Overdose Risk: Learning Objectives:
- Review the trends in benzodiazepine prescribing
- Evaluate risks of co-prescribing benzodiazepines and opioids
- Consider taper plans
- Recall importance of risk reduction
Registration is Free – Advanced Registration is required. Light snacks will be provided.
The words we choose have an impact. How we talk about drug use and people who use drugs is informed by our preconceived notions and internalized biases. When we use words like “clean,” we necessarily imply that the opposite is “dirty.” Opioid Use Disorder continues to be a highly stigmatized medical condition, despite many advancements in our understanding of the neurobiological, social, and environmental determinants that impact individual health. People with an Opioid Use Disorder continue to report high rates of discrimination from medical providers, service denials from government entities, and continued unfair targeting by law enforcement. The ramifications of stigma in care environments are far reaching and further compound the opioid crisis. During this workshop, participants will explore personal biases related to opioid use and examine the way that these biases present in language. We will consider the effects that stigmatizing speech and actions have on people who use drugs, and we will discuss how to create an affirming environment that will enhance care for people who use drugs.
Registration fee includes a continental breakfast and lunch.